Conduit Pharmaceuticals Inc. Cash Flow Quality Index
Conduit Pharmaceuticals Inc. cash flow quality index. Conduit Pharmaceuticals Inc. (CDT) has a Cash Flow Quality Index of 0.62x as of June 2026. Operating cash flow of $42.74 Million is below net income of $68.54 Million, suggesting accrual-heavy earnings not yet converted to cash. See financial flexibility index of Conduit Pharmaceuticals Inc. to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Conduit Pharmaceuticals Inc. Cash Flow Quality Index by Year (None–None)
Conduit Pharmaceuticals Inc. cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Conduit Pharmaceuticals Inc.. For the full cash flow conversion analysis, see how efficiently does Conduit Pharmaceuticals Inc. generate cash.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|